Skip to content
Hi-Doctor

How to Get Qsymia Online in Latvia

Qsymia is not currently approved for weight-loss prescription in the EU, including Latvia, and is not offered by Hi-Doctor. This article clarifies Qsymia's status and guides you to proven, EU-approved weight-loss treatments.

24 April 2026
How to Get Qsymia Online in Latvia —

DIRECT ANSWER

An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.

Less than 4 hours on average

Prescription issued in less than 4 hours on average if approved.

EU-licensed doctors

Every case is reviewed by a licensed clinician.

Valid across the EU

Approved prescriptions can be used at any EU pharmacy.

In this article

If you're searching for Qsymia online in Latvia, it's important to understand its current status. Qsymia is not currently approved for weight-loss prescription in the EU, and therefore, it is not legally available in Latvia. Hi-Doctor does not prescribe or offer Qsymia. However, we understand your interest in modern weight-loss solutions. This article will explain what Qsymia is, why it isn't a standard option yet, and importantly, what proven, EU-approved weight-loss treatments you CAN access today through an EU-licensed doctor.

What is Qsymia, and why isn't it a normal option yet?

Qsymia is a combination medication containing phentermine and topiramate. In some regions, it is prescribed for chronic weight management. Phentermine is an appetite suppressant, while topiramate is used for various conditions, including epilepsy and migraines, but also has weight-loss effects. In the EU, the European Medicines Agency (EMA) has not yet approved Qsymia for weight management. This means it has not completed the rigorous evaluation process required for legal prescription and sale within EU member states like Latvia. Any sources offering Qsymia online without EU approval are operating outside legal and safety regulations, posing significant health risks due to potential counterfeits or lack of medical oversight. It is crucial to avoid such unregulated sources for your safety.

Proven weight-loss medications available online today

While Qsymia isn't an option, several highly effective and EU-approved weight-loss medications are available through licensed medical professionals. Hi-Doctor connects you with EU-licensed doctors who can assess your suitability for these treatments:

  • Ozempic (semaglutide): A GLP-1 receptor agonist, Ozempic helps regulate appetite and blood sugar, leading to weight loss. It is primarily indicated for type 2 diabetes but is often used off-label for weight management.
  • Wegovy (semaglutide): Containing a higher dose of semaglutide than Ozempic, Wegovy is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
  • Mounjaro (tirzepatide): This medication is a dual GIP and GLP-1 receptor agonist, demonstrating powerful effects on weight loss and blood sugar control. It is approved for type 2 diabetes and increasingly used for weight management.
  • Saxenda (liraglutide): Another GLP-1 receptor agonist, Saxenda is approved for chronic weight management and works by helping you feel fuller and less hungry.

How to get a weight-loss prescription online in Latvia

Hi-Doctor offers a straightforward, secure path to accessing EU-approved weight-loss treatments with an EU-licensed doctor. Here’s how it works:

  1. Complete an online questionnaire: Spend 2–3 minutes providing essential medical information about your health and weight-loss goals.
  2. EU-licensed doctor reviews your case: An experienced doctor will carefully assess your information to determine if a weight-loss treatment is appropriate and safe for you.
  3. Receive an electronic prescription: If approved, a REMPE electronic prescription (a Spanish standard, valid EU-wide) will be issued within 24 hours. You'll receive a downloadable PDF in your secure patient account and by email.
  4. Pick up at any EU pharmacy: Print your prescription or show it on your phone at any pharmacy in any EU country, including Latvia, thanks to the cross-border prescription directive 2011/24/EU.

The online consultation costs a flat fee of 25 €. If the doctor determines treatment is not appropriate for you, this fee is automatically refunded.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight-loss solutions, safety and efficacy are paramount. Hi-Doctor provides a medically sound and regulated alternative to unregulated online peptide sellers:

  • EU-licensed doctors: All consultations are conducted by fully licensed medical professionals who adhere to EU medical standards.
  • Real medications, real pharmacies: You receive legitimate prescriptions for genuine, EU-approved medications, dispensed by any licensed pharmacy. This ensures traceability and product quality.
  • Auditable and compliant: Our platform is RGPD-compliant, ensuring your data privacy. All interactions and prescriptions are recorded and auditable.
  • Trusted service: With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor is a reputable and reliable choice for online medical care.
  • No 'research chemicals': Unlike grey-market vendors, we do not deal in unregulated substances or 'research chemicals' that lack medical oversight and can pose serious health risks.

Hi-Doctor is continuously onboarding new EU-licensed specialists across various conditions. If a specific treatment isn't covered today, you can register your interest at hi-doctor.ai to be notified when a doctor becomes available.

COMMON QUESTIONS

Frequently asked questions

No, Qsymia is not approved by the EMA and is therefore not legally available for purchase or prescription in Latvia or any other EU country.

Licensed EU doctors
Doctor review in less than 2 hours on average
50,000+ patients served
Secure patient account
Online Doctor Legitimacy and EU Regulations Explained — article cover image

Online Doctor Legitimacy and EU Regulations Explained

This article clarifies the legitimacy of online doctor services within the European Union, detailing the regulations that ensure patient safety and the validity of cross-border prescriptions.

14 August 2026
Understanding REMPE Electronic Prescriptions: A Guide for EU Patients — article cover image

Understanding REMPE Electronic Prescriptions: A Guide for EU Patients

This guide explains the Spanish REMPE electronic prescription system, its function within Spain, and its recognition across the EU. It clarifies how these prescriptions are reviewed and processed by pharmacists, both.

13 August 2026
Zavamed Alternatives: 8 Options Compared (2026) — article cover image

Zavamed Alternatives: 8 Options Compared (2026)

Looking for Zavamed alternatives in 2026? We compare 8 online health services by market, treatment coverage and supported consultation or fulfilment model.

6 August 2026
Dokteronline Alternatives: 8 Options Compared (2026) — article cover image

Dokteronline Alternatives: 8 Options Compared (2026)

Looking for Dokteronline alternatives? We compare 8 online healthcare services across the EU, UK and US, with clear market labels and service-model differences.

6 August 2026
Best Telehealth Men's Health Services in Spain (2026) — article cover image

Best Telehealth Men's Health Services in Spain (2026)

We compare seven telehealth men's health services available in Spain in 2026, from EU e-prescription platforms to doctor-directory and generalist services covering sexual health, hair growth and weight management.

6 August 2026
Best Online ED Treatment Providers in Europe (2026) — article cover image

Best Online ED Treatment Providers in Europe (2026)

Compare the top online ED treatment providers in Europe for 2026. We evaluate services by their consultation model, market availability, and approach to sexual healthcare.

6 August 2026

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.